This pattern suggests a context-dependent relationship: in populations with typically low adiponectin levels (such as healthy individuals), decreased levels are associated with higher mortality risk, while in populations with characteristically high levels (such as CKD patients), further elevation corresponds to increased mortality. This evidence concerns the gene ADIPOQ and chronic kidney disease.